Human Molecular Genetics, 1999, Vol. 8, No. 7 1279-1289
© 1999 Oxford University Press
Allelic and locus heterogeneity in inherited venous malformations
Departments of 1Genetics, 2Medicine (Cardiology), 3Pathology and Medicine (Dermatology) and 7Medicine (Medical Genetics), Duke University Medical Center, Durham, NC 27710, USA, 4Northern Ireland Regional Genetics Centre, Belfast, UK, 5Department of Medical Genetics, Aberdeen Royal Hospitals, Aberdeen, UK and 6Institute of Gerontology, University of Michigan, Ann Arbor, MI 48109, USA
Venous malformations are low-flow vascular lesions consisting of disorganized thin-walled vascular channels. These can occur sporadically but also as an autosomal dominant condition termed venous malformations, cutaneous and mucosal (VMCM; OMIM 600195). In two large unrelated kindreds mapping to chromosome 9, the identical R849W missense mutation was identified in the first kinase domain of Tie2, an endothelial cell-specific receptor tyrosine kinase. We report here the identification of four new kindreds with inherited venous malformations. Unlike the initial two families described, these four families demonstrate allelic and locus heterogeneity. In one of these families, the R849W mutation co-segregates with the disease phenotype. Three other families with venous malformations lack this mutation. One of these families is linked to markers near TIE2 on chromosome 9. In this family, we identified a novel mutation within the first kinase domain of Tie2 resulting in a Y897S change. Results from COS-1 cell transfections using expression constructs containing either the R849W or the Y897S mutation suggest that the receptors containing either mutation show ligand-independent hyperphosphorylation. These results suggest a gain-of-function mechanism for development of venous malformations in these families. Of the two remaining families, one excludes linkage to the TIE2 locus, establishing the existence of at least one additional locus for dominantly inherited venous malformations.
a To whom correspondence should be addressed. Tel: +1 919 684 3290; Fax: +1 919 681 9193; Email: march004{at}mc.duke.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Limaye, L. M. Boon, and M. Vikkula From germline towards somatic mutations in the pathophysiology of vascular anomalies Hum. Mol. Genet., April 15, 2009; 18(R1): R65 - R74. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brouillard and M. Vikkula Genetic causes of vascular malformations Hum. Mol. Genet., October 15, 2007; 16(R2): R140 - R149. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Macdonald, P. Progias, B. Ciani, S. Patel, U. Mayer, M. O. Steinmetz, and R. A. Kammerer Structure of the Extracellular Domain of Tie Receptor Tyrosine Kinases and Localization of the Angiopoietin-binding Epitope J. Biol. Chem., September 22, 2006; 281(38): 28408 - 28414. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bogdanovic, V. P. K. H. Nguyen, and D. J. Dumont Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization J. Cell Sci., September 1, 2006; 119(17): 3551 - 3560. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Voskas, N. Jones, P. Van Slyke, C. Sturk, W. Chang, A. Haninec, Y. O. Babichev, J. Tran, Z. Master, S. Chen, et al. A Cyclosporine-Sensitive Psoriasis-Like Disease Produced in Tie2 Transgenic Mice Am. J. Pathol., March 1, 2005; 166(3): 843 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Tille and M.S. Pepper Hereditary Vascular Anomalies: New Insights Into Their Pathogenesis Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1578 - 1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Boon, J. B. Mulliken, O. Enjolras, and M. Vikkula Glomuvenous Malformation (Glomangioma) and Venous Malformation: Distinct Clinicopathologic and Genetic Entities Arch Dermatol, August 1, 2004; 140(8): 971 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. North, T. Kahn, M. R. Cordisco, S. S. Dadras, M. Detmar, and I. J. Frieden Multifocal Lymphangioendotheliomatosis With Thrombocytopenia: A Newly Recognized Clinicopathological Entity Arch Dermatol, May 1, 2004; 140(5): 599 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Peters, C. D. Kontos, P. C. Lin, A. L. Wong, P. Rao, L. Huang, M. W. Dewhirst, and S. Sankar Functional Significance of Tie2 Signaling in the Adult Vasculature Recent Prog. Horm. Res., January 1, 2004; 59(1): 51 - 71. [Abstract] [Full Text] |
||||
![]() |
P. D. Thomas, M. J. Campbell, A. Kejariwal, H. Mi, B. Karlak, R. Daverman, K. Diemer, A. Muruganujan, and A. Narechania PANTHER: A Library of Protein Families and Subfamilies Indexed by Function Genome Res., September 1, 2003; 13(9): 2129 - 2141. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iurlaro, M. Scatena, W.-H. Zhu, E. Fogel, S. L. Wieting, and R. F. Nicosia Rat aorta-derived mural precursor cells express the Tie2 receptor and respond directly to stimulation by angiopoietins J. Cell Sci., September 1, 2003; 116(17): 3635 - 3643. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-L. Niu, K. G. Peters, and C. D. Kontos Deletion of the Carboxyl Terminus of Tie2 Enhances Kinase Activity, Signaling, and Function. EVIDENCE FOR AN AUTOINHIBITORY MECHANISM J. Biol. Chem., August 23, 2002; 277(35): 31768 - 31773. [Abstract] [Full Text] [PDF] |
||||







